Key result
Intraprocedural angiography safely guides mid/high-septal ventricular lead implantation in ~96% of CHD patients.
Why the study?
Conduction system pacing can be challenging in congenital heart disease, making mid/high septal lead implantation an alternative, but the utility of intraprocedural angiography to guide this was unassessed.
Does intraprocedural angiography-guided mid/high-septal lead implantation improve successful lead positioning and preserve systemic ventricular function in patients with congenital heart disease?
Observational (n=27)
No
Does intraprocedural angiography-guided mid/high-septal lead implantation improve successful lead positioning and preserve systemic ventricular function in patients with congenital heart disease?
Intraprocedural angiography is a safe and useful method to guide mid/high-septal lead implantation in patients with congenital heart disease, which helps preserve systemic ventricular function over medium-term follow-up.
Supports angiography-guided septal lead placement in CHD; hypothesis-generating for ventricular function preservation pending RCTs.
Background Conduction system pacing prevents pacing‐induced cardiomyopathy, but it can be challenging to perform in patients with congenital heart disease (CHD), and mid/high septal lead implantation is an alternative. This study aimed to assess intraprocedural angiography's utility as a guide for mid/high‐septal lead implantation in CHD patients. Methods The study subjects were CHD patients with Class I/IIa indications for permanent pacemaker implantation. To guide septal lead implantation, we performed an intraprocedural right ventricular angiogram in anteroposterior, 40° left anterior oblique, and 30° right anterior oblique. The primary endpoint was the lead tip in the mid/high septum on computed tomography (CT). The secondary endpoints were complications and systemic ventricular function on follow‐up. Results From January 2008 to December 2018, we enrolled 27 patients (mean age: 30 ± 20 years; M:F 17:10) with CHD (unoperated: 20, operated: 7). The mean paced QRS duration was 131.7 ± 5.8 ms, and CT done in 22/27 patients confirmed the lead tip in the mid‐septum in 16, high septum in 5, and apical septum in 1 patient. There were no procedural complications, and during a mean follow‐up of 58 ± 35.2 months, there was no significant change in the systemic ventricular ejection fraction (56.4 ± 8.3% vs 53.9 + 5.9%, P = .08). Two patients with Eisenmenger syndrome died because of refractory heart failure. Conclusions Intraprocedural angiography is safe and useful to guide mid/high‐septal lead implantation in CHD patients. Mid/high septal lead position preserves systemic ventricular function in patients with CHD during medium‐term follow‐up.
No takes yet. Share an insight, caveat, or question.
Shenthar et al. (2021) conducted an observational in Congenital heart disease with indication for permanent pacemaker (n=27). Angiography-guided mid/high septal implantation of ventricular leads was evaluated on Successful implantation of the ventricular lead in the mid/high septal position with no periprocedural complications. Intraprocedural angiography successfully guided mid/high-septal ventricular lead implantation in 95.5% of evaluated patients with congenital heart disease, with no procedural complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: